News

VIPC Awards Regional Innovation Ecosystem Grant to Verge to Accelerate the Growing Innovation Economy Throughout Roanoke and The New River Valley

The Virginia Innovation Partnership Corporation (VIPC) announced that Roanoke and Blacksburg, Virginia-based Verge has been awarded a Regional Innovation Fund (RIF) grant for $200,000. Verge is the region’s front door for innovators, founders, and funders to work together and to provide a growing roster of companies – both startups and established – with resources to grow and thrive, creating positive economic impact across the region and within the Commonwealth of Virginia.

Verge’s programs build, connect, and support the regional tech- and biotech-based entrepreneurial and innovation economic ecosystem. Its flagship program, the Regional Accelerator and Mentoring Program (RAMP), has recently expanded to include “Exit RAMP” to further support startups after their RAMP-in-Residence experience with a heavy focus on access to capital. Exit RAMP support includes ongoing programming, focused mentorship, network-building events, and annual memberships to the Roanoke-Blacksburg Technology Council (RBTC) and Virginia Bio. At the other side of the spectrum is “On RAMP,” which includes efforts to increase the pipeline of entrepreneurs and startups in the region and state. On RAMP programming focuses on navigating the local, regional, and statewide ecosystem support network to better prepare startups for acceleration and reduce their barriers to entry.

Over the past three years, RAMP has nurtured 30 startups, who have launched 35 new products into market and created 97 jobs. RIF funding, in addition to a Verge GO Virginia Strengthening Entrepreneurs’ Impact Grant, will help RAMP expand the On RAMP and Exit RAMP initiatives, effectively broadening RAMP’s overall potential impact.

“Verge is highly regarded as a key resource for grants, strategy, and thought leadership throughout Virginia,” stated Erin Burcham, President of Verge. “We are deeply committed to advancing both regional and statewide priorities through ongoing strategic planning, connecting entrepreneurs with top-tier resources, and establishing robust technology-focused economic partnerships across the region, state, and nation. Building a strong ecosystem requires the involvement of the entire community and a network of stakeholders, and as we engage them to broaden our reach and impact, this additional RIF grant is immensely valuable. We are grateful for VIPC’s continued support.”

Verge will also use new RIF funding to continue to strengthen its support of, partnerships with, and the overall expansion of other entrepreneurial support organizations located within the region and across the state, including local governments, higher education, and community-based support organizations. As part of its coalition-building and ecosystem-sustaining work, Verge will continue to work with regional stakeholders and statewide partners to develop resources and collaborations that resolve gaps in the entrepreneurial pipeline and ecosystem as identified through Verge’s ongoing research.

Joe Benevento, VIPC President and CEO, said, “Verge has been a great collaborative partner with VIPC, regional stakeholders, and local entrepreneurs. We look forward to seeing Verge help foster continued regional innovation growth and a thriving entrepreneurial ecosystem supportive of high-impact startup companies that contribute to the Commonwealth’s economic prosperity.”

“Innovation is happening daily across Virginia, and it’s so important to have an organization like Verge as a resource and support for local founders and startups,” said Conaway Haskins, VIPC’s Vice President of Entrepreneurial Ecosystems. “Verge will continue to facilitate new and existing alliances across the regions to expand their support where it can be most impactful. We’ve already seen the impact RIF funding has had on Verge’s operations in the past, and we’re pleased to help them extend their offerings and affect an even greater number of entrepreneurs.”

 

Learn more here.

Recent News

08/25/2026

United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the FDA has accepted the New Drug Application (NDA) for ralinepag to treat PAH. The FDA has set a Prescription Drug User Fee Act target action date of June 24, 2027. Ralinepag has not been approved for use in any indication by the

08/19/2026

ATCC Receives New CDC Award to Advance Influenza Testing and Surveillance

ATCC has been selected by the Centers for Disease Control and Prevention (CDC) for a new contract to support serological assays for the detection and characterization of influenza viruses. The award, valued at up to $7.3 million over the 5-year contract period (contract 75D30126C21030), will support CDC’s National Center for Immunization and Respiratory Diseases, Influenza

08/18/2026

Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

Nanochon, a medical device company developing Chondrograft™, a novel patented implant for the treatment of articular cartilage defects of the knee, today announced that it has received regulatory approval from Panamá’s Ministry of Health to initiate its First-in-Human (FIH) clinical study in Panamá. The study will evaluate the safety and performance of Chondrograft™ in patients